{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T16:44:47Z","timestamp":1793378687692,"version":"4.5.0"},"reference-count":48,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2021,12,27]],"date-time":"2021-12-27T00:00:00Z","timestamp":1640563200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,1,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>GammaTile\u00ae (GT) is a recent U.S. Food and Drug Administration (FDA) cleared brachytherapy platform. Here, we report clinical outcomes for recurrent glioblastoma patients after GT treatment following maximal safe resection.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We prospectively followed twenty-two consecutive Isocitrate Dehydrogenase (IDH) wild-type glioblastoma patients (6 O6-Methylguanine-DNA methyltransferase methylated (MGMTm); sixteen MGMT unmethylated (MGMTu)) who underwent maximal safe resection of recurrent tumor followed by GT placement.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The cohort consisted of 14 second and eight third recurrences. In terms of procedural safety, there was one 30-day re-admission (4.5%) for an incisional cerebrospinal fluid leak, which resolved with lumbar drainage. No other wound complications were observed. Six patients (27.2%) declined in Karnofsky Performance Score (KPS) after surgery due to worsening existing deficits. One patient suffered a new-onset seizure postsurgery (4.5%). There was one (4.5%) 30-day mortality from intracranial hemorrhage secondary to heparinization for an ischemic limb. The mean follow-up was 733 days (range 279\u20131775) from the time of initial diagnosis. Six-month local control (LC6) and twelve-month local control (LC12) were 86 and 81%, respectively. Median progression-free survival (PFS) was comparable for MGMTu and MGMTm patients (~8.0 months). Median overall survival (OS) was 20.0 months for the MGMTu patients and 37.4 months for MGMTm patients. These outcomes compared favorably to data in the published literature and an independent glioblastoma cohort of comparable patients without GT treatment.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>This clinical experience supports GT brachytherapy as a treatment option in a multi-modality treatment strategy for recurrent glioblastomas.<\/jats:p><\/jats:sec>","DOI":"10.1093\/noajnl\/vdab185","type":"journal-article","created":{"date-parts":[[2021,12,27]],"date-time":"2021-12-27T19:24:54Z","timestamp":1640633094000},"source":"Crossref","is-referenced-by-count":26,"title":["GammaTile\u00ae brachytherapy in the treatment of recurrent glioblastomas"],"prefix":"10.1093","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0067-7444","authenticated-orcid":false,"given":"Dominic J","family":"Gessler","sequence":"first","affiliation":[{"name":"Department of Neurosurgery, University of Minnesota, Minneapolis, Minnesota, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth C","family":"Neil","sequence":"additional","affiliation":[{"name":"Department of Neurology, University of Minnesota, Minneapolis, Minnesota, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rena","family":"Shah","sequence":"additional","affiliation":[{"name":"Department of Oncology, North Memorial Health, Robbinsdale, Minnesota, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Levine","sequence":"additional","affiliation":[{"name":"Department of Oncology, North Memorial Health, Robbinsdale, Minnesota, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Shanks","sequence":"additional","affiliation":[{"name":"Department of Oncology, Fairview Cancer Care, Minneapolis, Minnesota, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Wilke","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, University of Minnesota, Minneapolis, Minnesota, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret","family":"Reynolds","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, University of Minnesota, Minneapolis, Minnesota, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunqing","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, University of Minnesota, Minneapolis, Minnesota, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Can","family":"\u00d6z\u00fctemiz","sequence":"additional","affiliation":[{"name":"Department of Radiology, University of Minnesota, Minneapolis, Minnesota, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet","family":"Gencturk","sequence":"additional","affiliation":[{"name":"Department of Radiology, University of Minnesota, Minneapolis, Minnesota, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Folkertsma","sequence":"additional","affiliation":[{"name":"Department of Radiology, University of Minnesota, Minneapolis, Minnesota, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W Robert","family":"Bell","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Minnesota, Minneapolis, Minnesota, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liam","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Minnesota, Minneapolis, Minnesota, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"Ferreira","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, University of Minnesota, Minneapolis, Minnesota, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn","family":"Dusenbery","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, University of Minnesota, Minneapolis, Minnesota, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clark C","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, University of Minnesota, Minneapolis, Minnesota, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,12,27]]},"reference":[{"key":"2022012512164021400_CIT0001","doi-asserted-by":"crossref","DOI":"10.4103\/0971-6203.50045","article-title":"Brachytherapy\u2014past, present and future","author":"Gupta","year":"1995","journal-title":"J Med Phys."},{"issue":"3","key":"2022012512164021400_CIT0002","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s11060-013-1139-x","article-title":"Immediate post-operative brachytherapy prior to irradiation and temozolomide for newly diagnosed glioblastoma","volume":"113","author":"Waters","year":"2013","journal-title":"J Neurooncol."},{"issue":"30","key":"2022012512164021400_CIT0003","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.2217\/fon-2020-0558","article-title":"GammaTile\u00ae: Surgically targeted radiation therapy for glioblastomas","volume":"16","author":"Gessler","year":"2020","journal-title":"Futur Oncol Lond Engl."},{"issue":"1","key":"2022012512164021400_CIT0004","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/1748-717X-8-97","article-title":"Initial and cumulative recurrence patterns of glioblastoma after temozolomide-based chemoradiotherapy and salvage treatment: a retrospective cohort study in a single institution","volume":"8","author":"Ogura","year":"2013","journal-title":"Radiat Oncol."},{"issue":"1","key":"2022012512164021400_CIT0005","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s11060-012-0983-4","article-title":"Failure pattern following complete resection plus radiotherapy and temozolomide is at the resection margin in patients with glioblastoma","volume":"111","author":"Petrecca","year":"2013","journal-title":"J Neurooncol."},{"issue":"9","key":"2022012512164021400_CIT0006","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1212\/WNL.30.9.907","article-title":"Assumptions in the radiotherapy of glioblastoma","author":"Hochberg","year":"1980","journal-title":"Neurology."},{"issue":"6","key":"2022012512164021400_CIT0007","doi-asserted-by":"crossref","first-page":"865","DOI":"10.3171\/jns.1987.66.6.0865","article-title":"Imaging-based stereotaxic serial biopsies in untreated intracranial glial neoplasms","volume":"66","author":"Kelly","year":"1987","journal-title":"J Neurosurg."},{"issue":"6","key":"2022012512164021400_CIT0008","doi-asserted-by":"crossref","first-page":"864","DOI":"10.3171\/jns.1987.67.6.0864","article-title":"Recurrent malignant gliomas: survival following interstitial brachytherapy with high-activity iodine-125 sources","volume":"67","author":"Gutin","year":"1987","journal-title":"J Neurosurg."},{"issue":"5","key":"2022012512164021400_CIT0009","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/S0360-3016(98)00159-X","article-title":"Randomized study of brachytherapy in the initial management of patients with malignant astrocytoma","volume":"41","author":"Laperriere","year":"1998","journal-title":"Int J Radiat Oncol Biology Phys."},{"issue":"2","key":"2022012512164021400_CIT0010","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1097\/00006123-200208000-00009","article-title":"The Brain Tumor Cooperative Group NIH trial 87-01: a randomized comparison of surgery, external radiotherapy, and carmustine versus surgery, interstitial radiotherapy boost, external radiation therapy, and carmustine","volume":"51","author":"Selker","year":"2002","journal-title":"Neurosurgery."},{"issue":"10","key":"2022012512164021400_CIT0011","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa043330","article-title":"Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma","volume":"352","author":"Stupp","year":"2005","journal-title":"New Engl J Med."},{"issue":"23","key":"2022012512164021400_CIT0012","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1001\/jama.2017.18718","article-title":"Effect of tumor-treating fields plus maintenance temozolomide vs maintenance temozolomide alone on survival in patients with glioblastoma: a randomized clinical trial","volume":"318","author":"Stupp","year":"2017","journal-title":"JAMA."},{"issue":"3","key":"2022012512164021400_CIT0013","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.brachy.2020.12.005","article-title":"First clinical implementation of GammaTile permanent brain implants after FDA clearance","volume":"20","author":"Ferreira","year":"2021","journal-title":"Brachytherapy."},{"issue":"8","key":"2022012512164021400_CIT0014","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1056\/NEJMoa0808710","article-title":"IDH1 and IDH2 mutations in gliomas","volume":"360","author":"Yan","year":"2009","journal-title":"New Engl J Med."},{"issue":"10","key":"2022012512164021400_CIT0015","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1001\/jamaneurol.2014.1205","article-title":"IDH Mutation in glioma: new insights and promises for the future","volume":"71","author":"Turkalp","year":"2014","journal-title":"JAMA Neurol"},{"key":"2022012512164021400_CIT0016","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3389\/fneur.2018.00127","article-title":"The clinical significance of O6-Methylguanine-DNA methyltransferase promoter methylation status in adult patients with glioblastoma: a meta-analysis","volume":"9","author":"Zhao","year":"2018","journal-title":"Front Neurol."},{"issue":"34","key":"2022012512164021400_CIT0017","doi-asserted-by":"crossref","first-page":"5743","DOI":"10.1200\/JCO.2009.23.0805","article-title":"Molecular predictors of progression-free and overall survival in patients with newly diagnosed glioblastoma: a prospective translational study of the German Glioma Network","volume":"27","author":"Weller","year":"2009","journal-title":"J Clin Oncol."},{"issue":"1","key":"2022012512164021400_CIT0018","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/1479-5876-10-36","article-title":"MGMT promoter methylation in gliomas-assessment by pyrosequencing and quantitative methylation-specific PCR","volume":"10","author":"H\u00e5vik","year":"2012","journal-title":"J Transl Med."},{"issue":"4","key":"2022012512164021400_CIT0019","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/0360-3016(92)90703-K","article-title":"Interstitial brachytherapy for newly diagnosed patients with malignant gliomas: The UCSF experience","volume":"24","author":"Prados","year":"1992","journal-title":"Int J Radiat Oncol Biology Phys."},{"issue":"3","key":"2022012512164021400_CIT0020","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.ijrobp.2007.03.061","article-title":"Phase I trial of gross total resection, permanent Iodine-125 brachytherapy, and hyperfractionated radiotherapy for newly diagnosed glioblastoma multiforme","volume":"69","author":"Chen","year":"2007","journal-title":"Int J Radiat Oncol Biology Phys."},{"issue":"6","key":"2022012512164021400_CIT0021","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.3171\/2018.7.JNS18656","article-title":"Resection and permanent intracranial brachytherapy using modular, biocompatible cesium-131 implants: results in 20 recurrent, previously irradiated meningiomas","volume":"131","author":"Brachman","year":"2019","journal-title":"J Neurosurg."},{"issue":"1","key":"2022012512164021400_CIT0022","doi-asserted-by":"crossref","first-page":"CNS28","DOI":"10.2217\/cns-2018-0007","article-title":"Use of the response assessment in neuro-oncology (RANO) criteria in clinical trials and clinical practice","volume":"8","author":"Chukwueke","year":"2019","journal-title":"CNS Oncol"},{"issue":"1","key":"2022012512164021400_CIT0023","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ijrobp.2006.11.053","article-title":"GliaSite brachytherapy boost as part of initial treatment of glioblastoma multiforme: a retrospective multi-institutional pilot study","volume":"68","author":"Welsh","year":"2007","journal-title":"Int J Radiat Oncol Biology Phys."},{"issue":"4","key":"2022012512164021400_CIT0024","doi-asserted-by":"crossref","first-page":"356","DOI":"10.5114\/jcb.2019.87230","article-title":"Placement of 131 Cs permanent brachytherapy seeds in a large combined cavity of two resected brain metastases in one setting: case report and technical note","volume":"11","author":"Greenwald","year":"2019","journal-title":"J Contemp Brachyther."},{"issue":"6","key":"2022012512164021400_CIT0025","doi-asserted-by":"crossref","first-page":"772","DOI":"10.3109\/02688697.2013.791664","article-title":"MGMT promoter methylation status and prognosis of patients with primary or recurrent glioblastoma treated with carmustine wafers","volume":"27","author":"Gutenberg","year":"2013","journal-title":"Brit J Neurosurg."},{"issue":"8","key":"2022012512164021400_CIT0026","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.2217\/fon.16.9","article-title":"Patient outcomes following second surgery for recurrent glioblastoma","volume":"12","author":"Brandes","year":"2016","journal-title":"Future Oncol."},{"issue":"20","key":"2022012512164021400_CIT0027","doi-asserted-by":"crossref","first-page":"4783","DOI":"10.1002\/cncr.24546","article-title":"Prognostic impact of O6-methylguanine-DNA methyltransferase silencing in patients with recurrent glioblastoma multiforme who undergo surgery and carmustine wafer implantation","volume":"115","author":"Metellus","year":"2009","journal-title":"Cancer."},{"issue":"4","key":"2022012512164021400_CIT0028","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1634\/theoncologist.2016-0254","article-title":"Role of MGMT methylation status at time of diagnosis and recurrence for patients with glioblastoma: clinical implications","volume":"22","author":"Brandes","year":"2017","journal-title":"Oncol."},{"issue":"5","key":"2022012512164021400_CIT0029","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S1470-2045(09)70025-7","article-title":"Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial","volume":"10","author":"Stupp","year":"2009","journal-title":"Lancet Oncol."},{"issue":"6","key":"2022012512164021400_CIT0030","doi-asserted-by":"crossref","first-page":"475","DOI":"10.3109\/02841867809128178","article-title":"Postoperative irradiation of glioblastomas: results in a randomized series","volume":"17","author":"Andersen","year":"2009","journal-title":"Acta Radiologica Oncol Radiat Phys Biology."},{"issue":"1","key":"2022012512164021400_CIT0031","doi-asserted-by":"crossref","first-page":"3811","DOI":"10.1038\/s41467-020-17512-x","article-title":"Purine metabolism regulates DNA repair and therapy resistance in glioblastoma","volume":"11","author":"Zhou","year":"2020","journal-title":"Nat Commun."},{"issue":"1","key":"2022012512164021400_CIT0032","doi-asserted-by":"crossref","first-page":"4116","DOI":"10.1038\/s41467-020-17885-z","article-title":"OSMR controls glioma stem cell respiration and confers resistance of glioblastoma to ionizing radiation","volume":"11","author":"Sharanek","year":"2020","journal-title":"Nat Commun."},{"issue":"12","key":"2022012512164021400_CIT0033","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1016\/j.dnarep.2006.07.007","article-title":"Genetic analysis of ionizing radiation-induced mutagenesis in Saccharomyces cerevisiae reveals TransLesion Synthesis (TLS) independent of PCNA K164 SUMOylation and ubiquitination","volume":"5","author":"Chen","year":"2006","journal-title":"DNA Repair (Amst)."},{"key":"2022012512164021400_CIT0034","doi-asserted-by":"crossref","first-page":"102736","DOI":"10.1016\/j.ebiom.2020.102736","article-title":"Radiation-induced extracellular vesicle (EV) release of miR-603 promotes IGF1-mediated stem cell state in glioblastomas","volume":"55","author":"Ramakrishnan","year":"2020","journal-title":"Ebiomedicine."},{"issue":"3","key":"2022012512164021400_CIT0035","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1007\/s10143-020-01331-1","article-title":"Assessing the efficacy of repeat resections in recurrent glioblastoma: a systematic review","volume":"44","author":"Botros","year":"2021","journal-title":"Neurosurg Rev."},{"issue":"5","key":"2022012512164021400_CIT0036","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.3171\/2017.6.JNS17393","article-title":"The relationship between repeat resection and overall survival in patients with glioblastoma: a time-dependent analysis","volume":"129","author":"Goldman","year":"2018","journal-title":"J Neurosurg."},{"issue":"1","key":"2022012512164021400_CIT0037","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s11060-017-2564-z","article-title":"Treatment outcome of patients with recurrent glioblastoma multiforme: a retrospective multicenter analysis","volume":"135","author":"van Linde","year":"2017","journal-title":"J Neurooncol."},{"issue":"5","key":"2022012512164021400_CIT0038","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1227\/00006123-198711000-00001","article-title":"Reoperation in the treatment of recurrent intracranial malignant gliomas","volume":"21","author":"Ammirati","year":"1987","journal-title":"Neurosurgery."},{"issue":"5","key":"2022012512164021400_CIT0039","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.surneu.2007.03.043","article-title":"Repeated surgery for glioblastoma multiforme: only in combination with other salvage therapy","volume":"69","author":"Mandl","year":"2008","journal-title":"Surg Neurol."},{"issue":"5","key":"2022012512164021400_CIT0040","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.ccr.2010.03.017","article-title":"Identification of a CpG Island methylator phenotype that defines a distinct subgroup of glioma","volume":"17","author":"Noushmehr","year":"2010","journal-title":"Cancer Cell."},{"issue":"8","key":"2022012512164021400_CIT0041","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1200\/JCO.2008.19.4969","article-title":"Recurrence pattern after temozolomide concomitant with and adjuvant to radiotherapy in newly diagnosed patients with glioblastoma: correlation with MGMT promoter methylation status","volume":"27","author":"Brandes","year":"2009","journal-title":"J Clin Oncol."},{"issue":"1","key":"2022012512164021400_CIT0042","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s12916-016-0623-5","article-title":"Cancer immunotherapy: the beginning of the end of cancer?","volume":"14","author":"Farkona","year":"2016","journal-title":"BMC Med."},{"issue":"3","key":"2022012512164021400_CIT0043","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s11864-019-0619-4","article-title":"Current state of immunotherapy for treatment of glioblastoma","volume":"20","author":"McGranahan","year":"2019","journal-title":"Curr Treat Option On."},{"issue":"4","key":"2022012512164021400_CIT0044","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1093\/neuonc\/noz216","article-title":"Extensive brainstem infiltration, not mass effect, is a common feature of end-stage cerebral glioblastomas","volume":"22","author":"Drumm","year":"2019","journal-title":"Neuro Oncol."},{"issue":"3","key":"2022012512164021400_CIT0045","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/S0090-3019(98)00056-1","article-title":"Graphic analysis of microscopic tumor cell infiltration, proliferative potential, and vascular endothelial growth factor expression in an autopsy brain with glioblastoma","volume":"51","author":"Nagashima","year":"1999","journal-title":"Surg Neurol."},{"issue":"2","key":"2022012512164021400_CIT0046","doi-asserted-by":"crossref","first-page":"103","DOI":"10.4103\/0019-5413.77126","article-title":"Three-minute critical appraisal of a case series article","volume":"45","author":"Chan","year":"2011","journal-title":"Indian J Orthop."},{"issue":"10","key":"2022012512164021400_CIT0047","first-page":"1171","article-title":"Retrospective studies and chart reviews","volume":"49","author":"Hess","year":"2004","journal-title":"Respir Care."},{"issue":"2","key":"2022012512164021400_CIT0048","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j..2002.384.doc.x","article-title":"Design and analysis of pilot studies: recommendations for good practice","volume":"10","author":"Lancaster","year":"2004","journal-title":"J Eval Clin Pract."}],"container-title":["Neuro-Oncology Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/noa\/advance-article-pdf\/doi\/10.1093\/noajnl\/vdab185\/41937422\/vdab185.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/noa\/article-pdf\/4\/1\/vdab185\/42267437\/vdab185.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/noa\/article-pdf\/4\/1\/vdab185\/42267437\/vdab185.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,14]],"date-time":"2023-11-14T22:13:56Z","timestamp":1700000036000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/noa\/article\/doi\/10.1093\/noajnl\/vdab185\/6484612"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,27]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1,1]]}},"URL":"https:\/\/doi.org\/10.1093\/noajnl\/vdab185","relation":{},"ISSN":["2632-2498"],"issn-type":[{"value":"2632-2498","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,1,1]]},"published":{"date-parts":[[2021,12,27]]},"article-number":"vdab185"}}